Related Experiment Videos
Incidence of nerve damage in leprosy patients treated with MDT
Abstract:
The incidence rates of sensory and motor impairments during and after multidrug therapy (MDT) are reported for a prospective cohort of patients who had no nerve damage at registration (N = 1621). Sensory and motor loss increased with age and both were high among multibacillary patients as compared with paucibacillary patients. The lateral popliteal (common peroneal) and posterior tibial nerves seem to be most affected for sensory loss; whereas the posterior tibial and ulnar nerves are mainly responsible for motor loss. No significant difference by gender was found. Implications for prevention of disability (POD) activities are discussed and suitable recommendations made.
Insights
Multidrug therapy (MDT) can cause sensory and motor impairments, particularly in older, multibacillary leprosy patients. Nerve damage affects the lateral popliteal, posterior tibial, and ulnar nerves, highlighting the need for prevention of disability activities.
Area of Science:
- Neurology
- Dermatology
- Public Health
Background:
- Leprosy treatment involves multidrug therapy (MDT).
- Nerve damage is a significant complication of leprosy.
- Understanding impairment incidence during MDT is crucial for patient care.
Purpose of the Study:
- To report incidence rates of sensory and motor impairments during and after MDT.
- To identify risk factors for nerve damage in leprosy patients.
Main Methods:
- Prospective cohort study of 1621 leprosy patients with no initial nerve damage.
- Monitoring for sensory and motor impairments during and after MDT.
Main Results:
- Sensory and motor impairments increased with age.
- Higher incidence in multibacillary leprosy compared to paucibacillary.
- Lateral popliteal, posterior tibial, and ulnar nerves were most affected.
- No significant gender-based differences observed.
Conclusions:
- Age and disease type (multibacillary) are key risk factors for MDT-related nerve damage.
- Targeted prevention of disability strategies are needed for high-risk groups.
- Monitoring nerve function during and after MDT is essential.